Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Olaf Hedrich"'
Autor:
Azhar Ahmad, Elaine M. Hylek, Phil Mendys, Megan Coylewright, Sean D. Pokorney, Olaf Hedrich, Bernard J. Gersh, Sana M. Al-Khatib, Parashar Patel, Norman Stockbridge, Melanie Blank, Gerald V. Naccarelli, Christopher B. Granger, Robert Temple, Eva Kline-Rogers, Michael J. Mirro, Eric D. Peterson, Peter M DiBattiste, Howard Rutman, Christian T. Ruff, Jeff S. Healey
Publikováno v:
American heart journal. 210
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Current Treatment Options in Cardiovascular Medicine. 7:3-13
Heart failure (HF) is highly prevalent in our society and its incidence is increasing in concert with the growing aged population. Experimental and clinical studies have consistently shown that HF is ameliorated by inhibition of the renin-angiotensin
Publikováno v:
Coronary Artery Disease. 15:291-297
Dilated cardiomyopathy (DCM) is traditionally divided into ischemic and non-ischemic etiologies. We review data from clinical trials that suggest some patients in the latter subgroup develop ischemic complications including fatal myocardial infarctio
Publikováno v:
EP Europace. 18:i151-i151
Publikováno v:
Heart Failure: Pharmacologic Management
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65f14d532ad8a7602d617dcc765c1802
https://doi.org/10.1002/9780470994740.ch13
https://doi.org/10.1002/9780470994740.ch13
Publikováno v:
Heart failure clinics. 1(1)
The evolution of the notion that neurohormonal activation is central to the progression of heart failure (HF) is based mainly on studies of the effects of inhibiting the renin–angiotensin–aldosterone system (RAAS) and sympathetic nervous system i
Autor:
Domenico Corrado, Gianfranco Buja, Mark S. Link, N.A. Mark Estes, Olaf Hedrich, Thomas Wichter
Publikováno v:
Arrhythmogenic RV Cardiomyopathy/Dysplasia ISBN: 9788847004894
The management of patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) has evolved considerably over the last several years. Because many patients with ARVC/D may be at risk for sudden cardiac death (SCD) and clinical seri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f83443ab701787be9b4397f62106f115
https://doi.org/10.1007/978-88-470-0490-0_21
https://doi.org/10.1007/978-88-470-0490-0_21
Publikováno v:
Current cardiology reports. 8(5)
The impact of sudden cardiac death (SCD) in athletes has been highlighted by increasing media coverage, as well as medical and lay awareness of the entities associated with SCD. Common etiologies include cardiac abnormalities such as hypertrophic car